173 related articles for article (PubMed ID: 7956674)
1. Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management.
Pontiroli AE; Calderara A; Pozza G
Diabetes Metab Rev; 1994 Apr; 10(1):31-43. PubMed ID: 7956674
[No Abstract] [Full Text] [Related]
2. New pharmacologic approaches to the treatment of diabetes.
Johnson DG; Bressler R
Spec Top Endocrinol Metab; 1984; 6():163-92. PubMed ID: 6151747
[No Abstract] [Full Text] [Related]
3. Insulin responses to sulfonylureas.
Cerasi E
Diabetes Res Clin Pract; 2002 Apr; 56(1):69-70; author reply 71. PubMed ID: 11879723
[No Abstract] [Full Text] [Related]
4. [Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].
Gendeleka GF
Lik Sprava; 2000 Mar; (2):72-4. PubMed ID: 10862482
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
Tatoń J; Koliński P
Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
[No Abstract] [Full Text] [Related]
6. [Secondary sulfonylurea failure].
Ratzmann KP
Dtsch Med Wochenschr; 1990 Sep; 115(37):1404-7. PubMed ID: 2205457
[No Abstract] [Full Text] [Related]
7. Symposium on diabetes mellitus and oral hypoglycaemic drugs. Summary.
Taft P
Aust N Z J Med; 1971 Aug; 1():Suppl 2:83-5. PubMed ID: 5005135
[No Abstract] [Full Text] [Related]
8. The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelines.
Tiengo A; Del Prato S
Diabetes Res Clin Pract; 1988; 4 Suppl 1():75-81. PubMed ID: 3042339
[No Abstract] [Full Text] [Related]
9. Hypoglycaemic and anti-hyperglycaemic drugs for the control of diabetes.
Bailey CJ
Proc Nutr Soc; 1991 Dec; 50(3):619-30. PubMed ID: 1809970
[No Abstract] [Full Text] [Related]
10. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes and insulin secretagogues.
Hormone Foundation
J Clin Endocrinol Metab; 2012 Mar; 97(3):37A-38A. PubMed ID: 22392961
[No Abstract] [Full Text] [Related]
12. Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: a preliminary report.
Takei I; Takayama S; Yamauchi A; Nakamoto S; Kitamura Y; Katsukawa F; Yamazaki H; Saruta T; Inoue S
Eur J Clin Nutr; 1998 Feb; 52(2):153-4. PubMed ID: 9505163
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
Evans AJ; Krentz AJ
Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
[No Abstract] [Full Text] [Related]
14. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
Waldhäusl W
Horm Metab Res; 1996 Sep; 28(9):517-21. PubMed ID: 8911990
[No Abstract] [Full Text] [Related]
15. [Oral hypoglycemic agents].
Pupo Ade A
AMB Rev Assoc Med Bras; 1986; 32(11-12):202-4. PubMed ID: 3299518
[No Abstract] [Full Text] [Related]
16. [Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents].
Blicklé JF; Andres E; Neyrolles N; Brogard JM
Rev Med Interne; 1999 Aug; 20 Suppl 3():351s-359s. PubMed ID: 10480186
[TBL] [Abstract][Full Text] [Related]
17. [Progress in studies on antidiabetic agents].
Tang L; Yang YS; Ji RY
Yao Xue Xue Bao; 2001 Sep; 36(9):711-5. PubMed ID: 12580115
[No Abstract] [Full Text] [Related]
18. Does insulin preserve beta-cell function in type 2 diabetes?
Heise T; Sawicki PT
J Intern Med; 2002 Apr; 251(4):283-5. PubMed ID: 11952878
[No Abstract] [Full Text] [Related]
19. Sulfonylurea treatment of insulin-independent diabetes mellitus.
Feinglos MN; Lebovitz HE
Metabolism; 1980 May; 29(5):488-94. PubMed ID: 6990184
[TBL] [Abstract][Full Text] [Related]
20. Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents.
Iavicoli M; Cucinotta D; De Mattia G; Lunetta M; Morsiani M; Pontiroli AE; Pozza G
Diabet Med; 1988 Dec; 5(9):849-55. PubMed ID: 2976646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
